Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Publication year range
1.
Mol Biol (Mosk) ; 55(4): 617-625, 2021.
Article in Russian | MEDLINE | ID: mdl-34432779

ABSTRACT

MUC4 is a predominant membrane-tethered mucin lubricating and protecting the epithelial surface and playing various biological roles in the renewal and differentiation of epithelial cells, cell signaling, cell adhesion, and carcinogenesis. Interestingly, recent studies have demonstrated that MUC4 expression regulates the epithelial-mesenchymal transition (EMT) of cancer cells in ovarian, pancreatic, and lung cancer. However, the effects of MUC4 expression on EMT in human airway epithelial cells are not yet well known. Here, we describe the effects of transforming growth factor beta 1 (TGF-ß1)-induced MUC4 expression on EMT and evaluate its downstream signaling pathway in human airway epithelial cells. In human airway epithelial NCI-H292 cells, exposure to TGF-ß1 induced expression of MUC4, CDH2, VIM and SNAI1 genes and encoded by them proteins, MUC4, N-cadherin, vimentin and Snail, and reduced the level of CDH1 and its product, E-cadherin. In MUC4-knockdown cells, TGF-ß1-induced expression levels of MUC4, CDH2, VIM and SNAI1 and corresponding proteins were suppressed, but CDH1 and E-cadherin levels were not. In addition, TGF-ß1-induced phosphorylation of extracellular signal regulated kinase 1/2 (ERK1/2) was suppressed, but that of Smad2/3, Akt, and p38 was not. The results of this study suggest that MUC4 silencing inhibits TGF-ß1 -induced EMT via the ERK1/2 pathway, and a possible role of MUC4 in the induction of EMT in human airway epithelial cells.


Subject(s)
Epithelial-Mesenchymal Transition , Transforming Growth Factor beta1 , Epithelial Cells/metabolism , Epithelial-Mesenchymal Transition/genetics , Humans , MAP Kinase Signaling System , Mitogen-Activated Protein Kinase 3/genetics , Mucin-4/genetics , Mucin-4/metabolism , Transforming Growth Factor beta1/genetics
3.
Rhinology ; 58(1): 66-73, 2020 Feb 01.
Article in English | MEDLINE | ID: mdl-31680128

ABSTRACT

BACKGROUND: Airway inflammation and excessive mucin production are pathophysiological characteristics of airway diseases. Fipronil, a pesticide, is being extensively used in agriculture and veterinary medicine worldwide. However, this compound impairs immune function in non-target organisms. The present study aimed to evaluate the effect of fipronil on pro-inflammatory cytokine and mucus production and signalling pathways in human primary nasal METHODOLOGY: The effect of fipronil on pro-inflammatory cytokine and MUC5AC expression and the signalling pathway of fipronil were investigated using real-time PCR, enzyme immunoassays, immunofluorescence, and immunoblot analysis with specific inhibitors and small interfering RNA. RESULTS: Fipronil treatment increased pro-inflammatory cytokine interleukin (IL)-1beta, IL-6, IL-8, and MUC5AC expression in human primary nasal epithelial cells. It also induced phosphorylation of extracellular signal-regulated kinase 1/2 (ERK1/2) mitogenactivated protein kinase (MAPK), p38 MAPK, and nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kB). MAPK and NF-kB inhibitor treatment significantly inhibited increases in IL-1beta, IL-6, IL-8, and MUC5AC expression. Ex vivo data confirmed that fipronil-induced MUC5AC expression occurs through ERK1/2, p38, and NF-kB signalling pathways in nasal inferior turbinate tissue. CONCLUSIONS: Fipronil induced pro-inflammatory cytokine IL-1beta, IL-6, IL-8, and MUC5AC expression via ERK1/2 MAPK, p38 MAPK, and NF-kB in human primary nasal epithelial cells.


Subject(s)
Cytokines/metabolism , Epithelial Cells/drug effects , Mucin 5AC/metabolism , Pyrazoles/pharmacology , Cells, Cultured , Epithelial Cells/metabolism , Humans , NF-kappa B/metabolism , Signal Transduction , p38 Mitogen-Activated Protein Kinases/metabolism
4.
Endoscopy ; 33(2): 184-6, 2001 Feb.
Article in English | MEDLINE | ID: mdl-11272222

ABSTRACT

Treatment of gastrointestinal fistula usually consists of conservative management and surgery as definite therapeutic measure. Histoacryl can be used to treat gastrointestinal fistula with no response to conservative management in surgically high-risk patients. We report here three cases of gastrointestinal fistula successfully treated with endoscopic injection of Histoacryl through a catheter into the internal opening and fistulous tract.


Subject(s)
Enbucrilate/therapeutic use , Gastric Fistula/therapy , Intestinal Fistula/therapy , Enbucrilate/administration & dosage , Endoscopy , Female , Humans , Injections, Intralesional , Male , Middle Aged , Tissue Adhesives/administration & dosage , Tissue Adhesives/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...